Autoimmune cholangitis in a patient with thymoma
Version of Record online: 8 OCT 2004
Journal of Gastroenterology and Hepatology
Volume 19, Issue 11, pages 1324–1327, November 2004
How to Cite
KIM, J.-H., KIM, B.-H., KIM, Y.-W., PARK, J.-C., JUNG, Y. H., LEE, B. O., HAN, Y. S., DONG, S. H., KIM, H. J., CHANG, Y.-W., LEE, J. I. and CHANG, R. (2004), Autoimmune cholangitis in a patient with thymoma. Journal of Gastroenterology and Hepatology, 19: 1324–1327. doi: 10.1111/j.1440-1746.2002.03239.x
- Issue online: 8 OCT 2004
- Version of Record online: 8 OCT 2004
- Accepted for publication 8 September 2002.
- autoimmune cholangitis;
Abstract Autoimmune cholangitis is characterized biochemically by chronic cholestasis and histopathologically by chronic non-suppurative destructive cholangitis. It is associated with positive antinuclear antibody test and negative antimitochondrial antibody test results. Recently, we experienced a case of a 35-year-old woman with autoimmune cholangitis associated with thymoma who presented with pruritis, jaundice, chronic fatigue and anterior chest discomfort. Her laboratory examinations revealed marked increases in levels of serum alkaline phosphatase and gamma-glutamyl transpeptidase. In serological tests, antinuclear antibody was found, but antimitochondrial antibody was not. Liver biopsy findings were compatible with chronic non-suppurative destructive cholangitis. On computed tomography (CT) of the chest, a large anterior mediastinal mass was found. The mass was totally resected and the patient was treated with ursodeoxy cholic acid. Thereafter, her clinical symptoms improved and liver functions completely returned to the normal range. We describe here an uncommon association of autoimmune cholangitis with thymoma, which has not been reported previously in the English-written literature.